Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8729)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2020 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo JH, Liu SX, Gao S, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu P, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, Zhu X. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World J Gastroenterol 2020; 26(27): 3975-3988 [PMID: PMC7385562 DOI: 10.3748/wjg.v26.i27.3975] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i27/3975.htm |
| Number | Citing Articles |
| 1 |
Guang Cao, Xiaodong Wang, Hui Chen, Song Gao, Jianhai Guo, Peng Liu, Haifeng Xu, Liang Xu, Xu Zhu, Renjie Yang. Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02344-4
|
| 2 |
Junguo Liu, Jinjuan Zhang, Yijun Wang, Guiming Shu, Cheng Lou, Zhi Du. HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Medicine 2022; 101(51): e32390 doi: 10.1097/MD.0000000000032390
|
| 3 |
Yintao Wu, Jianyong Zhu, Hong Zhang, Nianxin Xia. The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma. Cancer Management and Research 2025; : 239 doi: 10.2147/CMAR.S481242
|
| 4 |
Zhuo Zhong, Jian Yang, Jing-Zi Luo, Xiong Xie, Zhi-Mei Huang, De Long. Efficacy of continuous arterial perfusion chemotherapy combined with transarterial chemoembolization regional arterial thermal perfusion in the treatment of pancreatic cancer with liver metastases. Oncology and Translational Medicine 2023; doi: 10.1097/ot9.0000000000000001
|
| 5 |
Shun-An Zhou, Qing-Mei Zhou, Lei Wu, Zhi-Hong Chen, Fan Wu, Zhen-Rong Chen, Lian-Qun Xu, Bi-Ling Gan, Hao-Sheng Jin, Ning Shi. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis. World Journal of Gastrointestinal Oncology 2024; 16(8): 3672-3686 doi: 10.4251/wjgo.v16.i8.3672
Abstract(218) |
Core Tip(266) |
Full Article(HTML)(1357)
|
Full Article with Cover (PDF)-2556K(84)
|
Audio-853K(5)
|
Peer-Review Report-171K(29)
|
Answering Reviewers-58K(27)
|
Supplementary Material-1360K(31)
|
Full Article (PDF)-2322K(74)
|
Full Article (XML)-221K(34)
|
Times Cited (6)
|
Total Visits (3171)
|
Open
|
| 6 |
Hua Yang, Mu-Zi-he Zhang, Hui-wei Sun, Yan-tao Chai, Xiaojuan Li, Qiyu Jiang, Jun Hou. A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.783194
|
| 7 |
Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami, Yasuhito Tanaka. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21472-1
|
| 8 |
Ling YANG, Zhen WANG, Dong D. WANG. Minimally invasive intervention combined with targeted immunotherapy achieves complete clinical response in advanced colorectal cancer: a case study and literature review. Minerva Biotechnology and Biomolecular Research 2024; 36(2) doi: 10.23736/S2724-542X.24.03126-2
|
| 9 |
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma. Cancers 2023; 15(13): 3347 doi: 10.3390/cancers15133347
|